RDR 02308
RDR 02308 is a TLR4-MyD88 binding inhibitor that inhibits full-length β-lactamase[1].
Product Specifications
CAS Number
4155-82-2
UNSPSC
12352005
Target
Bacterial; Beta-lactamase; Toll-like Receptor (TLR)
Type
Reference compound
Related Pathways
Anti-infection; Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/rdr-02308.html
Purity
98.0
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=[N+](C1=CC=C(C2=NN(C3=CC=CC=C3)C(C4=CC=CO4)C2)C=C1)[O-]
Molecular Formula
C19H15N3O3
Molecular Weight
333.34
References & Citations
[1]Lee HK, et al. Application of beta-lactamase enzyme complementation to the high-throughput screening of toll-like receptor signaling inhibitors. Mol Pharmacol. 2007 Oct;72 (4) :868-75.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC471237-500 1x 500 µL
P27 / KIP1 (DCS-72.F6 + KIP1/769 (SX53G8) ), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC942160-500 1x 500 µL
CD86 (Dendritic Cells Maturation Marker) (C86/2160R), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
